Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
about
Review of the use of Topiramate for treatment of psychiatric disordersThe multimodal treatment of eating disorders.Binge eating disorder: the next generation of researchThe efficacy of self-help group treatment and therapist-led group treatment for binge eating disorderTopiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Topiramate in the treatment of substance-related disorders: a critical review of the literatureDiagnosis and management of binge eating disorderAdd-on topiramate reduces weight in overweight patients with affective disorders: a clinical case seriesComorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.Bipolar disorder in womenTowards the pharmacotherapy of eating disordersWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disordersPharmacotherapies for Overeating and Obesity.Tackling obesity: new therapeutic agents for assisted weight loss.Topiramate in the treatment of compulsive sexual behavior: case report.Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trialCurrent and emerging drug treatments for binge eating disorder.Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial.The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology.Pharmacological management of binge eating disorder: current and emerging treatment options.Current pharmacotherapy options for bulimia nervosa and binge eating disorder.Current and investigational antiobesity agents and obesity therapeutic treatment targets.Pharmacological treatment of eating disordersAn Update on Evidence-Based Psychosocial Treatments for Eating Disorders in Children and Adolescents.Update: new uses for lithium and anticonvulsants.Treatment of Adolescent Eating Disorders: Progress and Challenges.Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro.Biological therapies for eating disorders.New anticonvulsant medication uses in bipolar disorder.Pharmacological treatment of binge eating disorder: update review and synthesis.The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.New medication treatment options for bipolar disorders.Latest therapies for bipolar disorder. Looking beyond lithium.Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.Uses of topiramate in the treatment of alcohol dependence.Current and emerging directions in the treatment of eating disordersAdjunctive strategies in the treatment of refractory bipolar depression: clinician options in the absence of a systematic database.Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.Active Reward Processing during Human Sleep: Insights from Sleep-Related Eating Disorder
P2860
Q24523918-9C6D4323-88A9-40CC-A8A3-345D6C331158Q24541536-37D1CE33-3409-41CB-9A2B-B7000B4B9DA7Q24603637-92A16A1E-08ED-4DD9-97F3-EBFC29166C11Q24618496-6D830DCE-E3C6-4BF1-B0EA-ACD330761357Q24632593-0CE0F34F-FE9D-4744-AC27-B94254DDFEDBQ24633145-B267D4EB-B9A9-4BED-9682-AE12B90F2CE4Q24670069-AC639E98-C931-41F5-A980-4DD31FACC7BAQ24793223-B6B54A67-7CBC-473B-8FD3-F01C647F51BDQ24810652-FEE800AE-E548-453B-8942-388C690273F7Q26795404-EEF2C1C2-053E-43A5-BAC0-46C5E59B9547Q28206098-BEC96B0D-AF28-4C6F-87E7-7A0DF78D0A83Q28249390-C6B75900-A435-48D7-8FDE-06F21D764E0EQ30351879-E0327770-3142-4ADE-891F-3D75F036B2F7Q30401145-FCF3DB4E-32A9-4058-B9C7-F4AB04174F17Q30816315-9049341C-DA39-4E52-A422-B1CC245A30A9Q33615158-C2895CD3-B9DE-40F1-8F92-3E2BAD41FB48Q33634698-24E8EE6F-EA5A-4311-BA94-FA86393E78C7Q33830840-166B12A6-5EE8-44F9-A8BE-57F51153F8D4Q34133292-CF0E9699-9F05-4A41-849C-349A7812A990Q34278450-D08A3936-95EC-413E-B897-9892E9355CC2Q34297444-58AEA9FE-6C06-4BCC-BAE7-3B248BB927F8Q34344786-C280B47A-DDDD-4937-ACE2-394C2851F81CQ34396648-513B2D40-58B3-4256-BBD0-2593E6850C13Q34457733-EDBA4325-96EF-45FB-90D7-00B30523889CQ34710521-16D64AA0-803B-40E4-842E-0D9692BE695FQ34877274-4ABE34E9-AACD-49BA-BB87-821A1A33FF8FQ35046075-9F251BAC-843E-431F-904B-125539A0278AQ35215020-E7A51314-400B-4BBD-A5F3-393ABA9EB874Q35673095-5BDB1D81-1385-4219-8676-DDC0499B105CQ35817318-7854FBD8-6BCC-4729-947D-17C9422E4607Q35824087-0DFC2C1E-68C4-4883-BBF1-42C915E91AA3Q35872066-871D7713-906B-4D04-98F2-0E3AA71FD5EEQ36060748-8E94C935-F1FF-45E9-B763-CC862A8192EDQ36065939-9391773B-0469-4659-9FF7-401D16816A3FQ36106838-44CFDF71-5910-4C14-AD46-E9135D3409DCQ36139013-69988950-A5C4-4B8B-A23F-C80E97522B44Q36150672-363A017E-8C14-4C8A-B000-F8CCCBE99871Q36219670-3E46AF0F-99D3-44CB-B24A-24AB961B3DA5Q36414182-5AC13DFB-4872-4BD5-80E3-BAEC73938CA2Q36424688-73D41DFE-895C-48E4-9A84-75986D81223E
P2860
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@ast
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@en
type
label
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@ast
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@en
prefLabel
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@ast
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@en
P2093
P921
P1476
Topiramate in the treatment of ...... zed, placebo-controlled trial.
@en
P2093
James I Hudson
M Rezaul Karim
Marc Kamin
Nathan A Shapira
Norman R Rosenthal
Paul E Keck
Susan L McElroy
P304
P356
10.1176/APPI.AJP.160.2.255
P407
P577
2003-02-01T00:00:00Z